Free Trial
The Market Does Not Wait. MarketBeat All Access Alerts for $149
Get the Alerts
Claim MarketBeat All Access Sale Promotion

Synopsys, Inc. $SNPS Holdings Decreased by Robeco Institutional Asset Management B.V.

Synopsys logo with Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Robeco Institutional Asset Management cut its Synopsys stake by 43.5% in the third quarter, selling 204,461 shares and retaining 265,777 shares worth approximately $115.6 million. Institutional investors collectively own 85.47% of SNPS.
  • Synopsys insiders sold substantial amounts of stock under pre-arranged Rule 10b5-1 plans, including CEO Sassine Ghazi’s $6.8 million sale and Aart de Geus’s $10.3 million sale. Insiders sold $51.4 million of shares over the past 90 days.
  • Despite the selling, Synopsys reported quarterly revenue of $2.48 billion and adjusted EPS of $3.91, exceeding analyst expectations, while analysts maintain a Moderate Buy consensus with an average $575 price target. The company also authorized a $1 billion share-buyback program.
  • Tracking Synopsys through earnings season? MarketBeat All Access sends real-time alerts on ratings, earnings, and news — $149 a year, locked in for as long as you stay.

Robeco Institutional Asset Management B.V. trimmed its position in Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 43.5% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 265,777 shares of the semiconductor company's stock after selling 204,461 shares during the quarter. Robeco Institutional Asset Management B.V. owned 0.14% of Synopsys worth $115,597,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in SNPS. AMI Asset Management Corp raised its holdings in shares of Synopsys by 56.1% in the 3rd quarter. AMI Asset Management Corp now owns 80,884 shares of the semiconductor company's stock valued at $35,179,000 after purchasing an additional 29,065 shares in the last quarter. Kapitalo Investimentos Ltda bought a new position in shares of Synopsys during the third quarter valued at approximately $333,000. Bank Pictet & Cie Europe AG boosted its stake in shares of Synopsys by 176.6% during the third quarter. Bank Pictet & Cie Europe AG now owns 2,545 shares of the semiconductor company's stock valued at $1,107,000 after purchasing an additional 1,625 shares in the last quarter. Norway Savings Bank increased its holdings in Synopsys by 7.3% during the third quarter. Norway Savings Bank now owns 2,211 shares of the semiconductor company's stock valued at $962,000 after buying an additional 150 shares during the period. Finally, Sumitomo Mitsui DS Asset Management Company Ltd increased its holdings in Synopsys by 2.7% during the third quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 58,644 shares of the semiconductor company's stock valued at $25,507,000 after buying an additional 1,534 shares during the period. Institutional investors own 85.47% of the company's stock.

Insider Activity

In other news, CEO Sassine Ghazi sold 14,604 shares of the company's stock in a transaction on Thursday, October 15th. The stock was sold at an average price of $462.84, for a total transaction of $6,759,315.36. Following the transaction, the chief executive officer directly owned 76,865 shares of the company's stock, valued at approximately $35,576,196.60. This represents a 15.97% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Aart de Geus sold 24,641 shares of the stock in a transaction on Tuesday, September 1st. The shares were sold at an average price of $419.44, for a total value of $10,335,421.04. Following the sale, the insider owned 120,443 shares of the company's stock, valued at approximately $50,518,611.92. This represents a 16.98% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 117,163 shares of company stock valued at $51,366,457 in the last ninety days. 0.56% of the stock is currently owned by insiders.

Synopsys Stock Up 0.8%

NASDAQ:SNPS opened at $451.19 on Thursday. Synopsys, Inc. has a fifty-two week low of $362.55 and a fifty-two week high of $539.48. The stock has a market capitalization of $86.46 billion, a P/E ratio of 79.72, a P/E/G ratio of 1.82 and a beta of 1.21. The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.24 and a current ratio of 1.34. The company's 50-day simple moving average is $429.93 and its 200-day simple moving average is $443.08.

Synopsys (NASDAQ:SNPS - Get Free Report) last issued its quarterly earnings data on Wednesday, August 26th. The semiconductor company reported $3.91 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $3.67 by $0.24. The firm had revenue of $2.48 billion for the quarter, compared to the consensus estimate of $2.44 billion. Synopsys had a net margin of 11.43% and a return on equity of 6.24%. The company's quarterly revenue was up 42.4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $3.39 EPS. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. On average, equities analysts anticipate that Synopsys, Inc. will post 11.00 earnings per share for the current fiscal year.

Synopsys declared that its Board of Directors has authorized a stock buyback program on Monday, October 5th that allows the company to buy back $1.00 billion in shares. This buyback authorization allows the semiconductor company to buy up to 1.1% of its stock through open market purchases. Stock buyback programs are usually a sign that the company's leadership believes its shares are undervalued.

Analyst Ratings Changes

SNPS has been the subject of a number of recent research reports. Roth Capital raised shares of Synopsys to a "buy" rating in a research note on Friday, September 25th. UBS Group set a $570.00 target price on Synopsys in a research report on Thursday, August 27th. Mizuho cut their price target on Synopsys from $600.00 to $550.00 and set an "outperform" rating on the stock in a report on Thursday, August 27th. Benchmark reiterated a "buy" rating and issued a $570.00 price target on shares of Synopsys in a report on Thursday, August 27th. Finally, Rothschild & Co Redburn reduced their price target on Synopsys from $560.00 to $550.00 and set a "buy" rating for the company in a research report on Wednesday, September 23rd. One equities research analyst has rated the stock with a Strong Buy rating, twenty-two have assigned a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $575.00.

Read Our Latest Stock Report on SNPS

Synopsys Profile

(Free Report)

Synopsys, Inc is an electronic design automation (EDA) and semiconductor intellectual property company serving the global semiconductor and electronics industries. Its software helps engineers design, verify, test and manufacture advanced integrated circuits and electronic systems.

The company's products and services support digital and analog design, functional verification, design-for-test, manufacturing and semiconductor engineering workflows. Synopsys also provides reusable semiconductor IP, including processor cores, interface technologies, security solutions and other components used in system-on-chip designs.

In addition to its semiconductor design offerings, Synopsys provides software development and application security tools intended to help organizations identify and manage vulnerabilities and risks across the software development lifecycle.

See Also

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Synopsys Right Now?

Before you consider Synopsys, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.

While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines